Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 62 results for "astrazeneca"

Cipla gains 3% on final approval for generic Pulmicort Respules
Business Standard

Cipla gains 3% on final approval for generic Pulmicort Respules

The company has received final approval from the USFDA to market a generic version of Astrazeneca's Pulmicort Respules. SI Reporter | Mumbai Last Updated at November 17, 2017 12:18 IST Cipla was up 3.4% to Rs 613 on the BSE in intra-day trade after the ... Business Standard, 2 days ago

23 images for astrazeneca

Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 month ago
Money Control, 1 month ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Sify, 2 months ago
Money Control, 3 months ago
Money Control, 3 months ago
Money Control, 5 months ago
Money Control

Torrent Power, Bharat Seats, AstraZeneca Pharma hits 52-wk high on strong Q2 nos

Torrent Power has registered 129 percent jump in its Q2 net profit at Rs 321 crore and revenue was up 8 percent at Rs 2,915 crore.
 Money Control1 week ago AstraZeneca Pharma India Q2 net zooms to Rs 27.38 crore  Money Control1 week ago

Volumes jump at Thyrocare Technologies counter

Atul Auto, Rallis India, Ador Welding and Astrazeneca Pharma India are among the other stocks to see a surge in volumes on BSE today, 4 October 2017.
 Business Standard1 month ago Volumes jump at Kewal Kiran Clothing counter  Business Standard1 month ago Volumes jump at GE Power India counter  Business Standard2 months ago

Astrazeneca Pharma India to announce Quarterly Result

First Published: Fri, October 27 2017. 11:03 IST RECOMMENDED FOR YOU RECOMMENDED FOR YOU
 Business Standard3 weeks ago
Sify

AstraZeneca CEO not signing UK govt Brexit letter

Deep uncertainty about future terms of trade just 18 months before Brexit happens in March 2019
 Business Standard2 months ago AstraZeneca CEO, worried by Brexit, not signing UK govt letter  Reuters2 months ago

Chi-Med, AstraZeneca lung cancer drug shrinks resistant tumors

An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines. The treatment, which Hutchison China ...
 Reuters1 month ago AstraZeneca rebuilds cancer drug hopes with new lung data  Business Standard2 months ago

Nikkei recovers from near 4-month low after North Korea fears ebb

* Exporters gain ground * Takeda soars on news of tie-up with AstraZeneca By Ayai Tomisawa TOKYO, Aug 30 (Reuters) - Japan's Nikkei share averagerebounded on Wednesday morning, recovering from a nearfour-month low as Wall Street rose and the yen weakened ...
 Sify2 months ago

AstraZeneca ticks another box as U.S. approves severe asthma drug

LONDON (Reuters) - AstraZeneca has achieved another milestone in rebuilding its drug portfolio with U.S. approval of a drug for severe asthma as the company battles to put patent losses on older medicines behind it. FILE PHOTO: The logo of AstraZeneca is seen ...
 Reuters3 days ago FDA approves AstraZeneca's asthma drug  Reuters4 days ago AstraZeneca asthma drug tralokinumab disappoints again  Reuters2 weeks ago AstraZeneca wins early U.S. approval for blood cancer drug  Reuters2 weeks ago

AstraZeneca rides China wave as rival GlaxoSmithKline struggles

Ben Hirschler 3 Min Read LONDON (Reuters) - AstraZeneca ( ) is enjoying booming drug sales in China, helped by reforms to the country’s regulatory system and an increased sales force, in sharp contrast to its British rival GlaxoSmithKline ( ). FILE ...
 Reuters1 week ago AstraZeneca aims to offset drug setback at big cancer congress  Reuters2 months ago

AstraZeneca among backers as Swiss cancer biotech raises $200 million

An unlisted Swiss biotech company focused on developing “armed antibodies” to fight cancer has raised $200 million in a funding round backed by AstraZeneca and other private backers. FILE PHOTO: The logo of AstraZeneca is seen on medication ...
 Reuters3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less